LA
TDACW

Linden Advisors’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Linden Advisors’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.3K Hold
299,999
– – ﹤0.01% 513
2025
Q4 		$84.6K Hold
299,999
– – ﹤0.01% 413
2025
Q3 		$96K Hold
299,999
– – ﹤0.01% 347
2025
Q2 		$92.5K Hold
299,999
– – ﹤0.01% 321
2025
Q1 		$76.6K Buy
+299,999
New +$52.8K ﹤0.01% 249

Other funds holding TDACW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Linden Advisors's TDACW Position: Q1 2026 in Review

Linden Advisors held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 299,999 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Linden Advisors first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $96K in Q3 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Linden Advisors held 299,999 shares of Translational Development Acquisition Corp Warrants worth $44.3K as of Q1 2026.
  • Linden Advisors left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Linden Advisors's portfolio in Q1 2026, its #513 holding.
  • Linden Advisors first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • Linden Advisors's Translational Development Acquisition Corp Warrants position peaked at $96K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.